Ferenc Baska

Title: Ferenc Baska: Innovator in Pharmaceutical Chemistry

Introduction

Ferenc Baska is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug candidates. With a total of 2 patents, his work focuses on compounds that target specific receptor functions and address critical health issues.

Latest Patents

Baska's latest patents include "Triazolobenzazepines as vasopressin V1a receptor antagonists." This invention pertains to 5,6-dihydro-4H-[1,2,4]triazolo[4,3-a][1]benzazepine derivatives, which serve as V1a receptor modulators. The patent outlines the preparation process for these compounds and their potential use in treating diseases associated with V1a receptor function. Another significant patent is "Styryl quinazoline derivatives as pharmaceutically active agents." This invention relates to styryl quinazoline derivatives identified as new drug candidates for treating hematopoiesis dysfunctions and various forms of cancer, particularly myeloid leukemia. These compounds also show promise as antibacterial agents.

Career Highlights

Throughout his career, Ferenc Baska has worked with prominent companies in the pharmaceutical industry, including Richter Gedeon Nyrt. and Vichem Chemie Kutató Kft. His expertise in drug development has positioned him as a valuable contributor to advancements in medical science.

Collaborations

Baska has collaborated with notable professionals in his field, including Éva Bozó and Imre Bata. These partnerships have facilitated the exchange of ideas and fostered innovation in pharmaceutical research.

Conclusion

Ferenc Baska's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the field. His work continues to impact the development of new therapeutic agents, addressing critical health challenges.